13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001779763
Total reported value
$874.7M
$874.7M
27 檔
22.7%
During the Q1 2025 filing period, Iron Triangle Partners LP (CIK: 0001779763) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $874.7M across 27 reported positions.
In Q1 2025, Iron Triangle Partners LP displayed an active expansion posture, initiating 27 new positions and adding to 0 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including DVA, CAH, ABBV) accounted for 22.7% of total reported equity market value during Q1 2025.
Top New Position Initiated
DVA
市值: $48.9M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DVA | Davita Inc | Stock-Healthcare | 7.71% | — | +22.71% | |
| 2 | CAH | Cardinal Health Inc | Stock-Healthcare | 6.52% | -3.08% | EXIT | |
| 3 | ABBV | Abbvie Inc | Stock-Healthcare | 6.37% | -6.60% | EXIT | |
| 4 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 5.37% | — | +0.80% | |
| 5 | BSX | Boston Scientific CORP | Stock-Healthcare | 5.28% | +4.59% | NEW | |
| 6 | GMED | Globus Medical Inc - A | Stock-Healthcare | 4.98% | — | -48.91% | |
| 7 | THC | Tenet Healthcare CORP | Stock-Healthcare | 4.44% | -3.97% | EXIT | |
| 8 | PODD | Insulet CORP | Stock-Healthcare | 4.39% | — | -31.16% | |
| 9 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 4.36% | — | — | |
| 10 | ONC | Beone Medicines Ltd-adr | Stock-Other | 4.20% | — | — | |
| 11 | GH | Guardant Health Inc | Stock-Healthcare | 4.03% | -3.55% | EXIT | |
| 12 | A | Agilent Technologies Inc | Stock-Healthcare | 3.84% | — | -65.05% | |
| 13 | MMSI | Merit Medical Systems Inc | Stock-Healthcare | 3.83% | +3.89% | NEW | |
| 14 | NVST | Envista Holdings CORP | Stock-Healthcare | 3.35% | +2.95% | NEW | |
| 15 | DOCS | Doximity Inc-class A | Stock-Healthcare | 3.29% | +1.30% | +15.17% | |
| 16 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 2.78% | — | — | |
| 17 | AHCO | Adapthealth CORP | Stock-Other | 2.76% | +0.52% | — | |
| 18 | TWST | Twist Bioscience CORP | Stock-Other | 2.62% | — | -13.92% | |
| 19 | ARGX | Argenx Se - Adr | Stock-Healthcare | 2.60% | -1.04% | EXIT | |
| 20 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 2.56% | -2.62% | EXIT | |
| 21 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 2.54% | +2.87% | — | |
| 22 | ADPT | Adaptive Biotechnologies | Stock-Other | 2.50% | -3.87% | EXIT | |
| 23 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 2.34% | +6.12% | NEW | |
| 24 | TECH | Bio-techne CORP | Stock-Healthcare | 2.31% | +3.14% | NEW | |
| 25 | BTSG | Brightspring Health Services | Stock-Other | 2.06% | -1.37% | — | |
| 26 | EHABUSD | Enhabit Inc | Stock-Other | 1.58% | — | — | |
| 27 | TXG | 10x Genomics Inc-class A | Stock-Other | 1.38% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DVA | Davita Inc | — | NEW | New buy |
| 2 | CAH | Cardinal Health Inc | — | NEW | New buy |
| 3 | ABBV | Abbvie Inc | — | NEW | New buy |
| 4 | TEVA | Teva Pharmaceutical-sp Adr | — | NEW | New buy |
| 5 | BSX | Boston Scientific CORP | — | NEW | New buy |
| 6 | GMED | Globus Medical Inc - A | — | NEW | New buy |
| 7 | THC | Tenet Healthcare CORP | — | NEW | New buy |
| 8 | PODD | Insulet CORP | — | NEW | New buy |
| 9 | AZNN | Astrazeneca Plc-spons Adr | — | NEW | New buy |
| 10 | ONC | Beone Medicines Ltd-adr | — | NEW | New buy |
| 11 | GH | Guardant Health Inc | — | NEW | New buy |
| 12 | A | Agilent Technologies Inc | — | NEW | New buy |
| 13 | MMSI | Merit Medical Systems Inc | — | NEW | New buy |
| 14 | NVST | Envista Holdings CORP | — | NEW | New buy |
| 15 | DOCS | Doximity Inc-class A | — | NEW | New buy |
| 16 | ALNY | Alnylam Pharmaceuticals Inc | — | NEW | New buy |
| 17 | AHCO | Adapthealth CORP | — | NEW | New buy |
| 18 | TWST | Twist Bioscience CORP | — | NEW | New buy |
| 19 | ARGX | Argenx Se - Adr | — | NEW | New buy |
| 20 | NBIX | Neurocrine Biosciences Inc | — | NEW | New buy |
| 21 | JAZZ | Jazz Pharmaceuticals plc | — | NEW | New buy |
| 22 | ADPT | Adaptive Biotechnologies | — | NEW | New buy |
| 23 | ISRG | Intuitive Surgical Inc | — | NEW | New buy |
| 24 | TECH | Bio-techne CORP | — | NEW | New buy |
| 25 | BTSG | Brightspring Health Services | — | NEW | New buy |
| 26 | EHABUSD | Enhabit Inc | — | NEW | New buy |
| 27 | TXG | 10x Genomics Inc-class A | — | NEW | New buy |
According to official SEC Form 13F filings, Iron Triangle Partners LP reported a total U.S. public equity portfolio value of $874.7M across 27 disclosed positions in Q1 2025.
During Q1 2025, Iron Triangle Partners LP's top holdings by market value included DVA (7.7%)、CAH (6.5%)、ABBV (6.4%). The largest single position, DVA, represented 7.7% of total portfolio value.
In Q1 2025, Iron Triangle Partners LP made 27 total portfolio adjustments, initiating 27 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.